Unresectable advanced HBV-related liver cancer

Clinical trials for Unresectable advanced HBV-related liver cancer explained in plain language.

Never miss a new study

Get alerted when new Unresectable advanced HBV-related liver cancer trials appear

Sign up with your email to follow new studies for Unresectable advanced HBV-related liver cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Can adding interferon boost immunotherapy against liver cancer?

Disease control Recruiting now

This study tests whether adding pegylated interferon alpha-2b to standard targeted immunotherapy can help people with advanced liver cancer caused by hepatitis B. The trial enrolls adults with unresectable, intermediate-to-advanced disease who are already on antiviral therapy. Pa…

Matched conditions: UNRESECTABLE ADVANCED HBV-RELATED LIVER CANCER

Sponsor: Jinling Hospital, China • Aim: Disease control

Last updated Aug 20, 2026 00:00 UTC

Unresectable advanced HBV-related liver cancer

Get alerted when new Unresectable advanced HBV-related liver cancer trials appear

Can adding interferon boost immunotherapy against liver cancer?